Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 16 Aug 2022 for Epizyme, Inc..
Filing timeline
BuySaleRoy A. Beveridge
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Roy A. Beveridge: trading record in brief
Roy A. Beveridge is Chief Medical Officer of Humana Inc (36 filings) and Director of Epizyme, Inc. (6). The record has 42 filings published from June 20, 2016 to August 16, 2022: 17 grants, 17 option exercises, 4 sales and 4 other filings. No purchase.
The 4 sales total EUR 8,582,834, with a median of EUR 1,813,221. Three of them dominate, all at Humana Inc: EUR 4,013,421 on August 6, 2018, EUR 2,247,772 on February 19, 2019 and EUR 1,378,670 on November 8, 2018.
2018 is the busiest year, with 16 filings, ahead of 2017 (9) and 2016 (6). After 5 filings in 2019, the record holds only one in 2021 and 5 in 2022. No filing falls in the last twelve months.
The median publication delay is 3 days. The count of trades by Beveridge within 30 days of colleagues at Humana Inc is 3, 2 and 2. All of them in the same direction. Colleagues in order: Timothy S. Huval, Brian P. LeClaire and Bruce D. Broussard.
Companies and markets linked to Roy A. Beveridge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations42 total
20,341 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028868:0
25,696 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028868:1
8,928 shares@ US$1.4751.4% of flowCommon Stock, par value $0.0001SEC:0000899243-22-025017:0
8,994 shares0Common Stock, par value $0.0001SEC:0000899243-22-018808:0
11,413 shares@ US$1.1548.6% of flowCommon Stock, par value $0.0001SEC:0000899243-22-013155:0
16,702 shares0Common Stock, par value $0.0001SEC:0000899243-21-045212:0
100 shares0Humana CommonSEC:0000049071-19-000018:4
595 shares@ US$167.810.8% of flowHumana CommonSEC:0000049071-19-000018:0
325 shares@ US$307.220.8% of flowHumana CommonSEC:0000049071-19-000018:1
7,085 shares@ US$167.819.1% of flowHumana CommonSEC:0000049071-19-000018:2
8,278 shares@ US$307.1619.5% of flowHumana CommonSEC:0000049071-19-000018:3
520 shares@ US$304.051.2% of flowHumana CommonSEC:0000049071-18-000142:1
401 shares@ US$304.050.9% of flowHumana CommonSEC:0000049071-18-000142:3
163 shares@ US$304.050.4% of flowHumana CommonSEC:0000049071-18-000142:5
1,093 shares0Humana CommonSEC:0000049071-18-000142:0
843 shares0Humana CommonSEC:0000049071-18-000142:2
341 shares0Humana CommonSEC:0000049071-18-000142:4
4,622 shares@ US$341.0611.7% of flowHumana CommonSEC:0000049071-18-000126:0
1,291 shares@ US$81.800.8% of flowHumana CommonSEC:0000049071-18-000105:0
328 shares@ US$322.730.8% of flowHumana CommonSEC:0000049071-18-000105:1
607 shares@ US$164.650.7% of flowHumana CommonSEC:0000049071-18-000105:2
310 shares@ US$322.730.7% of flowHumana CommonSEC:0000049071-18-000105:3
14,306 shares@ US$164.6517.0% of flowHumana CommonSEC:0000049071-18-000105:4
14,306 shares@ US$324.2533.5% of flowHumana CommonSEC:0000049071-18-000105:5
104 shares0Humana CommonSEC:0000049071-18-000070:0
25 of 42 declarations
